While many treatment approaches for SAPHO syndrome remain a race between hope and challenge, a recent report in JAMA Dermatology has opened a new door: abrocitinib – a selective JAK1 inhibitor – ...
A case report published in JAMA Dermatology describes a rare condition called Cutaneous Collagenous Vasculopathy (CCV), which was diagnosed after the patient had lived with unexplained purpuric skin ...